Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 FY- Text added to 2023 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acetate, addressing, Adial, admission, Aerium, alemtuzumab, alert, AlgoTherapeutix, AlgoTx, alia, apparent, art, arterial, artificial, ASPR, attack, Aubagio, augment, Avonex, Axcella, Betaseron, biometric, breakthrough, broader, carcinogenic, categorized, caution, clarification, CODM, commensurate, Commerce, concise, contractor, Copaxone, corrupt, counsel, court, cyber, cybersecurity, debarment, decision, defense, dimethyl, disaggregated, disagree, disaster, EEA, email, engineering, environmental, erasure, explanation, explicitly, exploit, Extavia, extracorporeal, fall, faster, feasibility, feasible, figure, fine, fingolimod, firmly, fundamental, furnish, GDPR, genetic, geopolitical, Gilenya, glatiramer, Glatopa, Gohibic, handling, heavily, home, hope, Immunohistochemistry, ImmunoTech, imprisonment, incorrect, indirect, indirectly, infiltration, InflaRx, inspired, intelligible, inter, interferon, interpret, interpretation, InterveXion, introduction, invasive, invent, invention, inventor, irrevocable, knowledge, lapse, laundering, lawfully, leadership, Lemtrada, lessened, macroeconomic, mandated, Mapping, member, membrane, mmHg, mutagenic, natalizumab, nonexclusive, nontransferable, ODT, opting, overseeing, peginterferon, Plegridy, portability, predictor, principle, privacy, prompt, pseudonymized, Qalsody, qualification, quantity, RANO, rare, reacquired, readily, Rebif, reconciling, rectification, redefine, regime, registry, regularly, release, released, remediation, reproduction, resurgence, Retrospective, retrospectively, revocation, revoke, Rigel, rolipram, RSA, sanctioned, SBMT, sector, settled, SNO, social, soliciting, Sonnet, subcontractor, sum, supervisory, Supreme, tabular, Tascenso, Tecfidera, teriflunomide, terrorist, threshold, tofersen, Tonix, transmucosal, turnover, TVAX, Tyruko, Tysabri, undergo, unexercised, unitary, unsettled, UPC, USPTO, vehicle, ventilation, verification, viewed, vilobelimab, whichever, wide, WinSanTor
Removed:
analogized, compensatory, dated, denominated, FibroGen, iii, Intercept, Opiant, outlier, payroll, strain, tentative
Valuein 2022 FY filing- Value in 2023 FY filing
Original filings
Filing view